H51.2
Internuclear ophthalmoplegia
Clinical Classification Guidelines
Medical Intelligence & Overview
Internuclear ophthalmoplegia (INO) is a neurological condition affecting eye movement. It occurs when there is a disruption in the communication between the brain's nerve centers responsible for coordinating eye movements. As a result, individuals may experience double vision or difficulty focusing their eyes properly. INO typically indicates an underlying neurological issue, often related to multiple sclerosis or stroke, requiring medical evaluation and management.
Causes & Symptoms
Clinical Causes: Multiple sclerosis which damages the nerve pathways involved in eye movement Stroke affecting the brainstem where the nerve pathways are located Brain tumors or lesions that interfere with nerve signaling Traumatic brain injury causing damage to the coordinating nerves Infections or inflammatory conditions affecting the brainstem
Key Symptoms: Inability to coordinate eye movements properly Double vision, especially during horizontal gaze Difficulty focusing or tracking moving objects Weakness or paralysis of eye muscles on one side Nystagmus (uncontrolled eye movements) in affected eye Possible eyelid drooping or facial weakness depending on the underlying cause
Diagnostic & Treatment
Diagnosis Path: Diagnosing internuclear ophthalmoplegia involves a comprehensive eye examination and neurological assessment. Eye movement tests particularly evaluate the ability to move both eyes together. Imaging studies such as MRI are frequently used to identify the underlying brain abnormalities, such as lesions or tumors. Additional tests may include neurological exams and blood work to determine associated conditions like multiple sclerosis.
Treatment Protocols: Treatment of internuclear ophthalmoplegia focuses on addressing the underlying cause. Management may include disease-modifying therapies for multiple sclerosis, medications for stroke or other neurological conditions, and supportive therapies like vision rehabilitation. In some cases, prism glasses can help reduce double vision temporarily. Ongoing neurological care is essential to monitor and manage symptoms effectively.
Clinical Advice & FAQs
Billing Guidance
Is H51.2 a billable ICD-10 code?
Yes, H51.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H51.2?
Clinical documentation must specify the nature of Internuclear ophthalmoplegia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference